Introduction

In the last two decades, fixed bed reactors have started to be utilized in the pharmaceutical industry as a result of sustainability commitment and growing demand of complex and specialized drugs. Most of the engineering knowledge is transferable across industries; however, there are differentiators inherent to each industry, with the pharmaceutical industry having its own unique challenges with available catalysts which have the desired properties being the key constraint. This webinar will discuss these properties alongside a case study.

Speakers

• Lee Edwards Principal Investigator and GSK Fellow, United Kingdom

---

Contact information

Dr Fraser W Kerr
Astute Pharma Associates
0044 792 0082985
Contact us by email

---